ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-02-01
|
| Series: | Cardiology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40119-025-00399-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849309869855735808 |
|---|---|
| author | Neil Poulter |
| author_facet | Neil Poulter |
| author_sort | Neil Poulter |
| collection | DOAJ |
| format | Article |
| id | doaj-art-1daa6f419c7b461c85c66d5a99c6d82d |
| institution | Kabale University |
| issn | 2193-8261 2193-6544 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Cardiology and Therapy |
| spelling | doaj-art-1daa6f419c7b461c85c66d5a99c6d82d2025-08-20T03:53:57ZengAdis, Springer HealthcareCardiology and Therapy2193-82612193-65442025-02-0114211712110.1007/s40119-025-00399-4ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert ConsensusNeil Poulter0Preventive Cardiovascular Medicine, Imperial Clinical Trials Unit [ICTU], Imperial College Londonhttps://doi.org/10.1007/s40119-025-00399-4Angiotensin-converting enzyme inhibitorsAngiotensin receptor blockersCardiovascular outcomesHypertensionRandomised controlled trialsAll-cause mortality |
| spellingShingle | Neil Poulter ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus Cardiology and Therapy Angiotensin-converting enzyme inhibitors Angiotensin receptor blockers Cardiovascular outcomes Hypertension Randomised controlled trials All-cause mortality |
| title | ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus |
| title_full | ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus |
| title_fullStr | ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus |
| title_full_unstemmed | ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus |
| title_short | ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus |
| title_sort | ace inhibitors and angiotensin receptor blockers for the prevention of cardiovascular outcomes recommendations from the 2024 egyptian cardiology expert consensus |
| topic | Angiotensin-converting enzyme inhibitors Angiotensin receptor blockers Cardiovascular outcomes Hypertension Randomised controlled trials All-cause mortality |
| url | https://doi.org/10.1007/s40119-025-00399-4 |
| work_keys_str_mv | AT neilpoulter aceinhibitorsandangiotensinreceptorblockersforthepreventionofcardiovascularoutcomesrecommendationsfromthe2024egyptiancardiologyexpertconsensus |